Oncologic outcomes | Level | RCS (n = 143) | LCS (n = 155) | p-value |
---|---|---|---|---|
T-stage, n (%) | 0 | 1 (0.7%) | 5 (3.2%) | 0.237a |
1 | 35 (24.5%) | 27 (17.4%) | ||
2 | 24 (16.8%) | 28 (18.1%) | ||
3 | 70 (49.0%) | 74 (47.7%) | ||
4 | 13 (9.1%) | 21 (13.5%) | ||
N-stage, n (%) | 0 | 89 (62.2%) | 82 (52.9%) | 0.087a |
1 | 31 (21.7%) | 50 (32.3%) | ||
2 | 23 (16.1%) | 23 (14.8%) | ||
M-stage, n (%) | 0 | 143 (100%) | 152 (98.1%) | 0.043a |
1 | 0 (0%) | 3 (1.9%) | ||
Harvested lymph nodes, median (IQR) | 37 (28–47) | 34 (25–44) | 0.0610b | |
Microradical resection, n (%) | R0 | 137 (95.8%) | 145 (93.5%) | 0.388a |
R1 | 6 (4.2%) | 10 (6.5 %) |